AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Share Price Rises 8.36% Today to Rs 291
- August 25, 2026
- Posted by: Harsh Piplani
- Category: News
AVIENCE BIOMEDICALS LTD Share Price rose to Rs 291 today, up 8.36% from the previous close, with market capitalisation at Rs 140.36 Cr. The stock opened at Rs 278.95, touched an intraday high of Rs 300 and a low of Rs 278.95, while turnover stood at Rs 1.07 Cr. The data confirms a clear price rise in AVIENCE BIOMEDICALS LTD Share Price Today, but it does not establish a company-specific catalyst. In Univest’s reading, the move is best understood through the day’s price action, valuation metrics, sector benchmark and peer comparisons rather than speculation. Investors tracking AVIENCE BIOMEDICALS LTD Stock News can use today’s numbers to place the move in context and watch how the share price behaves around the Rs 300 level and the company’s broader financial profile.
AVIENCE BIOMEDICALS LTD Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 291 |
| Previous Close | Rs 268.55 |
| Today's Move | Rs 22.45 (+8.36%) |
| Open | Rs 278.95 |
| High | Rs 300 |
| Low | Rs 278.95 |
| Turnover | Rs 1.07 crore |
| Market Capitalisation | Rs 140.36 crore |
| Market Cap Category | Micro Cap |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) rose to Rs 291 from the previous close of Rs 268.55, a move of Rs 22.45 or 8.36%. The stock opened at Rs 278.95, reached a high of Rs 300, recorded a low of Rs 278.95.
AVIENCE BIOMEDICALS LTD Share Price Today closed at Rs 291 against the previous close of Rs 268.55, adding Rs 22.45 or 8.36%. The stock moved between Rs 278.95 and Rs 300 during the session, so the day ended near the upper part of the traded range. That makes the share price rise a straightforward same-day market event rather than a story built on unverified triggers. Turnover of Rs 1.07 Cr provides the traded-value context for the session, and Univest notes that the supplied data confirms the price event while leaving the underlying cause unconfirmed. For readers following AVIENCE BIOMEDICALS LTD Share Price Live, the key reference points are the current price, the day’s high and the gap versus the previous close.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 140.36 crore |
| P/E Ratio | 16.83x |
| P/B Ratio | 6.08x |
| ROE | 49.9% |
| ROCE | 34.16% |
| EPS | Rs 15.96 |
| Book Value Per Share | Rs 44.18 |
| Dividend Yield | 0% |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) fundamental metrics show P/E 16.83x, P/B 6.08x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.
AVIENCE BIOMEDICALS LTD has a market capitalisation of Rs 140.36 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.83x, P/B at 6.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.96, book value per share of Rs 44.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.24x, median ROE of 14%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 16.83x |
| Benchmark Median P/E | 30.24x |
| Benchmark Average P/E | 91.77x |
| Benchmark P/E Range | 7.86x to 1,121.12x |
| Company P/B Ratio | 6.08x |
| Benchmark Median P/B | 3.76x |
| Company ROE | 49.9% |
| Benchmark Median ROE | 14% |
| Company ROCE | 34.16% |
| Benchmark Median ROCE | 16.41% |
| Company Market Capitalisation | Rs 140.36 crore |
| Benchmark Median Market Cap | Rs 154.43 crore |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 16.83x, which is below the benchmark median of 30.24x, a difference of -44.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROE of 49.9%, which is above the benchmark median of 14%, a difference of +256.43%. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROCE of 34.16%, which is above the benchmark median of 16.41%, a difference of +108.17%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS LTD | LENSKART | 1,15,063.8 | 175.08 | 12.83 | 6.85 | 12.55 |
| Poly Medicure Ltd. | POLYMED | 17,411.37 | 55.91 | 5.54 | 10.94 | 14.05 |
| Q-LINE BIOTECH LIMITED | QLINE | 1,282.47 | 23.18 | 6.1 | 13.94 | 19.19 |
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,089.43 | 34.73 | 4.24 | 21.4 | 24.97 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,028.55 | 19.57 | 3.88 | 19.41 | 26.03 |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 16.83x compared with the displayed peer median of 34.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 49.9% compares with a peer median of 13.94% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 19.19%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a market capitalisation of Rs 140.36 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching AVIENCE BIOMEDICALS LTD
- AVIENCE BIOMEDICALS LTD Share Price rose 8.36% today to Rs 291 from Rs 268.55.
- The intraday range was Rs 278.95 to Rs 300, with turnover of Rs 1.07 Cr.
- Market capitalisation stands at Rs 140.36 Cr, slightly below the peer-group median of Rs 154.43 Cr.
- P/E is 16.83, while ROE is 49.9 and ROCE is 34.16, placing the company above sector medians on profitability.
- EPS is Rs 15.96, book value is Rs 44.18 and dividend yield is 0, which adds context to AVIENCE BIOMEDICALS LTD Stock News.
About AVIENCE BIOMEDICALS LTD
AVIENCE BIOMEDICALS LTD operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. Based on the available classification, its business context is tied to medical equipment and related accessories, which places it within a defined healthcare sub-segment rather than a broad pharmaceutical model. For readers tracking AVIENCE BIOMEDICALS LTD Stock News Today, the most relevant business context is its industry placement, valuation profile and profitability metrics rather than any unverified operating narrative. The company’s market capitalisation of Rs 140.36 Cr and its peer-group positioning suggest a smaller listed business inside a broader healthcare universe. Univest treats the company overview as a factual frame for understanding the share price rise, not as a substitute for company disclosures or financial statements.
Track AVIENCE BIOMEDICALS LTD Share Price on Univest
Use AVIENCE BIOMEDICALS LTD (AVIENCE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track AVIENCE BIOMEDICALS LTD Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels, fundamental ratios and market insights. Univest also helps users compare AVIENCE BIOMEDICALS LTD Stock Analysis with sector peers and monitor how the stock moves across sessions. For anyone following AVIENCE BIOMEDICALS LTD Latest News, this creates one place to review the share price, market cap, financial context and relevant company information without needing to piece together multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is AVIENCE BIOMEDICALS LTD rising today?
Ans. The data shows AVIENCE BIOMEDICALS LTD Share Price rose 8.36% to Rs 291, but it does not establish a company-specific catalyst. The move is confirmed by the day’s open, high, low, previous close and turnover.
What is AVIENCE BIOMEDICALS LTD Share Price today?
Ans. AVIENCE BIOMEDICALS LTD Share Price Today is Rs 291. It closed above the previous close of Rs 268.55 and traded between Rs 278.95 and Rs 300 during the session. The previous close was Rs 268.55.
How much did AVIENCE BIOMEDICALS LTD share price rise today?
Ans. AVIENCE BIOMEDICALS LTD Share Price rose by Rs 22.45, which is 8.36% higher than the previous close. That makes it a notable same-day share price gain in the supplied data.
What is the market capitalisation of AVIENCE BIOMEDICALS LTD?
Ans. The company’s market capitalisation is Rs 140.36 Cr. In the supplied peer set for the same industry, that is slightly below the median market cap of Rs 154.43 Cr. The company operates in the Healthcare sector.
How do AVIENCE BIOMEDICALS LTD valuation ratios compare with peers?
Ans. AVIENCE BIOMEDICALS LTD has a P/E of 16.83 and a P/B of 6.08. Its P/E is below the sector median of 30.24, while its P/B is above the median of 3.76.
What do AVIENCE BIOMEDICALS LTD profitability metrics show?
Ans. ROE is 49.9 and ROCE is 34.16, both above the supplied sector median and average. EPS is Rs 15.96 and book value is Rs 44.18, which adds detail to the profitability picture.
Does AVIENCE BIOMEDICALS LTD pay a dividend?
Ans. The dividend yield is 0, so no dividend yield is reflected in the supplied data. That makes earnings, book value and operating ratios more central to AVIENCE BIOMEDICALS LTD Fundamental Analysis.
How should investors read AVIENCE BIOMEDICALS LTD Share Price News?
Ans. AVIENCE BIOMEDICALS LTD Share Price News today is best read as a verified price rise alongside financial and sector context. The numbers confirm the move, while Univest separates facts from unsupported explanations.
